Nuo Therapeutics, Inc. (AURX)
USD 1.35
(-12.9%)
USD 1.35
(-12.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 608.52 Thousand | 112.25 Thousand | - | - | 146.17 Thousand | 1.37 Million |
| Cost of Revenue | 126.09 Thousand | 19.21 Thousand | - | - | 114.61 Thousand | 162.99 Thousand |
| Gross Profit | 482.43 Thousand | 93.03 Thousand | - | - | 31.56 Thousand | 1.2 Million |
| Operating Expenses | 3.65 Million | 3.41 Million | 90.67 Thousand | 378.05 Thousand | 1 Million | 2.71 Million |
| Selling, General and Administrative Expenses | 3.65 Million | 3.41 Million | 90.67 Thousand | 378.05 Thousand | 819.57 Thousand | 2.13 Million |
| Research and Development Expenses | - | - | - | - | 181.18 Thousand | 576.19 Thousand |
| Other Expenses | - | 4523.00 | - | - | -4237.00 | 1762.00 |
| Cost and Expenses | 3.77 Million | 3.43 Million | 90.67 Thousand | 378.05 Thousand | 1.11 Million | 2.87 Million |
| Operating Income | -3.16 Million | -3.32 Million | -90.67 Thousand | -378.05 Thousand | -969.19 Thousand | -1.5 Million |
| Interest Expense | 3162.00 | 2103.00 | - | 48.39 Thousand | 221.45 Thousand | 38.88 Thousand |
| Income Tax Expense | - | -146.43 Thousand | 287.18 Billion | 48.39 Thousand | 221.45 Thousand | 37.12 Thousand |
| Earnings before Tax | -3.17 Million | -3.17 Million | -90.67 Thousand | -90.87 Thousand | -1.19 Million | -1.54 Million |
| Net Income | -3.17 Million | -3.02 Million | -90.67 Thousand | -139.26 Thousand | -1.41 Million | -1.54 Million |
| Earnings Per Share Basic | -0.08 | -0.08 | -0.00 | -0.01 | -0.06 | -0.07 |
| Earnings Per Share Diluted | -0.08 | -0.08 | -0.00 | -0.01 | -0.06 | -0.07 |
| Weighted Average Shares Outstanding | 42.07 Million | 40 Million | 30.29 Million | 25.69 Million | 23.72 Million | 23.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.07 Million | 40 Million | 30.29 Million | 27.31 Million | 23.72 Million | 23.27 Million |
| Gross Margin | 0.79 | 0.83 | - | - | 0.22 | 0.88 |
| EBIT Margin | -5.03 | -28.88 | - | - | -6.66 | -1.02 |
| Profit Margin | -5.21 | -26.95 | - | - | -9.69 | -1.12 |
| EBITDA | -3.06 Million | -3.09 Million | - | -288.2 Thousand | -879.33 Thousand | -1.4 Million |
| Earnings Before Tax Margin | -5.21 | -29.58 | - | - | -6.63 | -1.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 364.77 Thousand | 234.57 Thousand | 608.52 Thousand | 197.01 Thousand | 232.24 Thousand | 118.16 Thousand |
| Cost of Revenue | 65.33 Thousand | 50.59 Thousand | 126.09 Thousand | 41.36 Thousand | 53.81 Thousand | 20.48 Thousand |
| Gross Profit | 299.43 Thousand | 183.98 Thousand | 482.43 Thousand | 155.64 Thousand | 178.42 Thousand | 97.68 Thousand |
| Operating Expenses | 841.42 Thousand | 893.23 Thousand | 3.65 Million | 807.75 Thousand | 967.97 Thousand | 969.1 Thousand |
| Selling, General and Administrative Expenses | 841.42 Thousand | 893.23 Thousand | - | 807.75 Thousand | 967.97 Thousand | 969.1 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1350.00 | - | - | - | - | - |
| Cost and Expenses | 906.75 Thousand | 943.82 Thousand | 3.77 Million | 849.12 Thousand | 1.02 Million | 989.59 Thousand |
| Operating Income | -541.98 Thousand | -709.25 Thousand | -3.16 Million | -652.11 Thousand | -789.53 Thousand | -871.42 Thousand |
| Interest Expense | 541.00 | 465.00 | 3162.00 | 1050.00 | 1087.00 | 463.00 |
| Income Tax Expense | 3.00 | -4.00 | 2.00 | 2.00 | -20.00 | -96.06 Thousand |
| Earnings before Tax | -540.09 Thousand | -708.78 Thousand | -3.17 Million | -653.15 Thousand | -790.64 Thousand | -871.88 Thousand |
| Net Income | -540.09 Thousand | -708.78 Thousand | -3.17 Million | -653.15 Thousand | -790.64 Thousand | -871.88 Thousand |
| Earnings Per Share Basic | -0.01 | -0.02 | - | -0.02 | -0.02 | -0.02 |
| Earnings Per Share Diluted | -0.01 | -0.02 | - | -0.02 | -0.02 | -0.02 |
| Weighted Average Shares Outstanding | 44.65 Million | 44.24 Million | 42.07 Million | 42.71 Million | 42.14 Million | 41.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.65 Million | 44.24 Million | 42.07 Million | 42.71 Million | 42.14 Million | 41.79 Million |
| Gross Margin | 0.82 | 0.78 | 0.79 | 0.79 | 0.77 | 0.83 |
| EBIT Margin | -1.43 | -2.91 | - | -3.17 | -3.29 | -7.15 |
| Profit Margin | -1.48 | -3.02 | -5.21 | -3.32 | -3.40 | -7.38 |
| EBITDA | -522.08 Thousand | -681.73 Thousand | - | -625.11 Thousand | -763.15 Thousand | -845.4 Thousand |
| Earnings Before Tax Margin | -1.49 | -3.02 | -5.21 | -3.31 | -3.40 | -7.37 |
TREAY
EQUITASBNK
GLATF
IOB
LDSN
SHPHF